Ascariasis medical therapy

Jump to navigation Jump to search

Ascariasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Ascariasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Future or Investigational Therapies

Case Studies

Case #1

Ascariasis medical therapy On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ascariasis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ascariasis medical therapy

CDC onAscariasis medical therapy

Ascariasis medical therapy in the news

Blogs on Ascariasis medical therapy

Hospitals Treating Ascariasis

Risk calculators and risk factors for Ascariasis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]

Overview

Antimicrobial therapy with albendazole is usually the treatment of choice for ascariasis, although other antihelminthic medications can effectively eradicate the parasite.[1]

Medical Therapy

All ascariasis infection (symptomatic and asymptomatic) should be treated with antimicrobial therapy.[2] Due to the high rate of reinfection, it is sometimes necessary to repeat antimicrobial therapy.[3]

Antihelminthic Regimen for Ascariasis[2][4][5][6][3]

  • Preferred regimen
  1. Albendazole 400 mg PO single dose. Albendazole dose for children between the ages of 1-2 years is 200 mg.
  2. Mebendazole 500 mg PO single dose or 100 mg bid for 3 days
  • Alternative regimen
  1. Ivermectin 150 to 200 µg/kg PO single dose
  2. Nitazoxanide 500 mg bid for 3 days (adolescents and adults); 200mg bid for 3 days (children 4-11 yrs of age); 100mg PO bid for 3 days (children 1-3 yrs of age)
  3. Levamisole 150 mg PO single dose. The pediatric dose is 2.5 mg/kg PO daily
  4. Pyrantel pamoate 11 mg/kg single dose PO, maximum 1.0 g
  5. Piperazine citrate 75 mg/kg/day for 2 days, maximum 3.5 g/day

Management of Intestinal obstruction

Intestinal obstruction due to ascariasis should be managed conservatively by:[2][3]

  • Nasogastric decompression
  • Fluid and electrolyte repletion
  • Antihelminthic therapy once bowel motility is restored. Piperazine causes flaccid paralysis of the worms and this can help relieve the obstruction through rapid expulsion of the worms. It is preferably administered as a syrup via a nasogastric tube when treating intestinal or biliary obstruction due to ascariasis.
  • Complete obstruction with inadequate decompression, lack of response within an interval of 24-48 hrs, volvulus, intussusception or perforation should be managed surgically.

Management of Biliary ascariasis[2]

  • Conservative management
  1. NG suction
  2. Antispasmodics
  3. Analgesics
  4. Intravenous fluids
  5. Antibiotics if evidence of bacterial infection
  6. Antihelminthic therapy
  • Endoscopic or surgical removal

References

  1. Kim, Kami; Weiss, Louis; Tanowitz, Herbert (2016). "Chapter 39:Parasitic Infections". Murray and Nadel's Textbook of Respiratory Medicine Sixth Edition. Elsevier. pp. 682–698. ISBN 978-1-4557-3383-5.
  2. 2.0 2.1 2.2 2.3 Durand, Marlene (2015). "Chapter 288:Intestinal Nematodes (Roundworms)". Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases Updated Edition, Eighth Edition. Elsevier. pp. 3199–3207. ISBN 978-1-4557-4801-3.
  3. 3.0 3.1 3.2 Kliegman, Robert; Stanton, Bonita; St. Geme, Joseph; Schor, Nina (2016). "Chapter 291:Ascariasis (Ascaris lumbricoides)". Nelson Textbook of Pediatrics Twentieth Edition. Elsevier. pp. 1733–1734. ISBN 978-1-4557-7566-8.
  4. Centers for Disease Control and Prevention.https://www.cdc.gov/parasites/ascariasis/health_professionals/index.html#tx Accessed on the 6th of March, 2017.
  5. Romero Cabello R, Guerrero LR, Muñóz García MR, Geyne Cruz A (1997). "Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico". Trans R Soc Trop Med Hyg. 91 (6): 701–3. PMID 9580117.
  6. Khuroo MS (1996). "Ascariasis". Gastroenterol Clin North Am. 25 (3): 553–77. PMID 8863040.


Template:WikiDoc Sources